Press

25. Nov. 2024

Aphaia Pharma to Participate in a Panel Discussion at the 1st Annual Obesity & Metabolic Innovation Forum

ZUG, Switzerland, SAN JUAN, Puerto Rico and TORONTO, November 25, 2024 – Aphaia Pharma, a clinical-stage company harnessing precision-targeted drug formulations to restore endogenous endocrine…

Read More

Press

25. Nov. 2024

43rd Annual J. P. Morgan Health Conference in San Francisco

From 10 - 16 January, Günter Jucho, CFO of Aphaia Pharma AG, will be attending the 43rd annual J. P. Morgan Healthcare Conference in San…

Read More